You buy raw materials, hold regulated stock and pay for compliance upfront, then wait 60 to 90 days for the NHS, pharmacy chains and wholesalers to pay. Invoice finance releases the cash tied up in your sales ledger so you can keep producing and shipping.
The specifics that make or break a facility in this sector.
NHS trusts, national pharmacy chains and chemical wholesalers are dependable payers but sit on long terms. Lenders are comfortable funding these names precisely because the credit risk is low, even when payment is slow.
Invoicing is often tied to batch release, and controlled or regulated products carry extra documentation. A lender used to the sector will underwrite around batch-level invoicing rather than treating it as a red flag.
A quarantine, quality hold or product recall can freeze an invoice until the issue clears. Sector-aware lenders build sensible dispute and verification handling into the facility so a hold does not stall your whole line.
GMP requirements and hazardous or temperature-controlled goods affect delivery proof and title. This rarely blocks funding, but the right lender will structure verification around how your product actually ships.
Move the slider to your typical invoice value to see what would hit your account and what it would cost.
We benchmark your facility across a panel of specialist invoice finance and revolving credit lenders, and match you with the ones whose appetite fits pharmaceuticals & chemicals. You get whole-of-market access from one conversation, at no cost to you.
We're collecting permission to publish a real client story for this sector. Get in touch if you'd like to be one of the first.
Yes. These are exactly the debtors invoice finance lenders like, because they pay reliably. The long terms are the reason you need the facility, not a barrier to getting it.
A free, no-obligation conversation with a broker who knows your sector. We do the legwork.
Get a quote →